Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Gains from Investment Securities (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Gains from Investment Securities data on record, last reported at $1.9 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 367.89% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $6.6 million, up 684.22%, while the annual FY2025 figure was $5.8 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $1.9 million in Q4 2025 per PBH's latest filing, up from -$4.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.9 million in Q4 2023 and bottomed at -$4.2 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $657555.6, with a median of $82000.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: plummeted 4591.36% in 2023, then soared 463.06% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.9 million in 2021, then skyrocketed by 90.67% to $5.6 million in 2022, then rose by 6.33% to $5.9 million in 2023, then tumbled by 112.01% to -$710000.0 in 2024, then skyrocketed by 367.89% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $1.9 million in Q4 2025, -$4.2 million in Q3 2025, and $4.1 million in Q2 2025.